NCT04664738 - PEP on a Skin Graft Donor Site Wound | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 16, 2021

Primary Completion Date

August 9, 2023

Study Completion Date

February 2, 2024

Conditions

Skin Graft

Interventions

BIOLOGICAL

10% PEP

PEP is comprised of platelet derived extracellular vesicles enriched in anti-inflammatory and angiogenic growth factors.

DRUG

TISSEEL

Fibrin sealant made from pooled human plasma

BIOLOGICAL

20% PEP

PEP is comprised of platelet derived extracellular vesicles enriched in anti-inflammatory and angiogenic growth factors.

Trial Locations (2)

International Research Partners, Doral

Mayo Clinic in Rochester, Rochester